John David Finley - 11 Jun 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Award	$0	+66,700		$0.000000	66,700	11 Jun 2023	Common Stock	66,700		Direct	F1, F2, F4
transaction	PALI	Common Stock Options	Award	$0	+148,500		$0.000000	148,500	11 Jun 2023	Common Stock	148,500	$1.60	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The Grants were made as discretionary grants to the Reporting Person, from the Issuer's 2021 Equity Incentive Plan, as amended. Each grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date, subject to Reporting Person continuing to be a service provider at the time of vesting.
F2	Each restricted stock unit represents the right to receive one share of common stock.
F3	Each option represents the right to purchase one share of common stock at the exercise price.
F4	N/A